Tenon Medical Inc. (TNON)
1.22
-0.11 (-8.27%)
At close: Apr 04, 2025, 2:46 PM
Company Description
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes.
It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico.
The company was founded in 2012 and is based in Los Gatos, California.
Tenon Medical Inc.
| Country | United States |
| IPO Date | Apr 27, 2022 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 27 |
| CEO | Steven M. Foster |
Contact Details
Address: 104 Cooper Court Los Gatos, California United States | |
| Website | https://www.tenonmed.com |
Stock Details
| Ticker Symbol | TNON |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001560293 |
| CUSIP Number | 88066N303 |
| ISIN Number | US88066N3035 |
| Employer ID | 45-5574718 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Steven M. Foster | Chief Executive Officer, President & Director |
| Kevin Williamson | Chief Financial Officer |
| Richard Ginn | Founder, Chief Technology Officer & Director |
| Richard M. Ferrari | Founder & Executive Chairman |
| Steve Moscaret | Senior Vice President of Sales & Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | 8-K | Current Report |
| Mar 27, 2025 | 8-K | Current Report |
| Mar 27, 2025 | 424B5 | Filing |
| Mar 26, 2025 | 10-K | Annual Report |
| Mar 26, 2025 | 424B5 | Filing |
| Mar 12, 2025 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Nov 12, 2024 | 424B3 | Filing |
| Nov 04, 2024 | S-1/A | [Amend] Filing |
| Oct 17, 2024 | S-1 | Filing |